All In Biotech

Drug Trial Radar · NCT06851910

Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia

Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia: A Prospective Observational Study

Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Apr 21, 2025

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Hospital Universitari de BellvitgeAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 28, 2025

More drug trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This prospective observational study evaluates the effectiveness and safety of intravenous lacosamide as a rescue treatment for acute pain in patients presenting to the emergency department with trigeminal neuralgia

Conditions

  • Trigeminal Neuralgia

Interventions

  • LacosamideDrug

    Patients will be included if they are prescribed intravenous lacosamide for their trigeminal neuralgia exacerbation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain reliefTime frame: 2 hours post-infusion
  2. Adverse effectsTime frame: Through study completion, an average of 1 week

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hospital de Bellvitge

    L'Hospitalet de Llobregat, Barcelona, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.